195 related articles for article (PubMed ID: 22718763)
1. Nonmuscle myosin II is required for internalization of the epidermal growth factor receptor and modulation of downstream signaling.
Kim JH; Wang A; Conti MA; Adelstein RS
J Biol Chem; 2012 Aug; 287(33):27345-58. PubMed ID: 22718763
[TBL] [Abstract][Full Text] [Related]
2. Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.
Bao J; Jana SS; Adelstein RS
J Biol Chem; 2005 May; 280(20):19594-9. PubMed ID: 15774463
[TBL] [Abstract][Full Text] [Related]
3. Nonmuscle myosin IIA dynamically guides regulatory light chain phosphorylation and assembly of nonmuscle myosin IIB.
Weißenbruch K; Fladung M; Grewe J; Baulesch L; Schwarz US; Bastmeyer M
Eur J Cell Biol; 2022 Apr; 101(2):151213. PubMed ID: 35257961
[TBL] [Abstract][Full Text] [Related]
4. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
Choi C; Kwon J; Lim S; Helfman DM
Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
[TBL] [Abstract][Full Text] [Related]
5. Non-muscle myosin IIB helps mediate TNF cell death signaling independent of actomyosin contractility (AMC).
Flynn PG; Helfman DM
J Cell Biochem; 2010 Aug; 110(6):1365-75. PubMed ID: 20564232
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.
Kajiya M; Ichimonji I; Min C; Zhu T; Jin JO; Yu Q; Almazrooa SA; Cha S; Kawai T
Mol Pharmacol; 2012 Jul; 82(1):115-24. PubMed ID: 22511543
[TBL] [Abstract][Full Text] [Related]
7. The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor.
Wills MK; Tong J; Tremblay SL; Moran MF; Jones N
Mol Biol Cell; 2014 Mar; 25(6):739-52. PubMed ID: 24430869
[TBL] [Abstract][Full Text] [Related]
8. Nonmuscle myosin-2: mix and match.
Heissler SM; Manstein DJ
Cell Mol Life Sci; 2013 Jan; 70(1):1-21. PubMed ID: 22565821
[TBL] [Abstract][Full Text] [Related]
9. Novel regulation and dynamics of myosin II activation during epidermal wound responses.
Betapudi V; Rai V; Beach JR; Egelhoff T
Exp Cell Res; 2010 Apr; 316(6):980-91. PubMed ID: 20132815
[TBL] [Abstract][Full Text] [Related]
10. Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.
Ma X; Jana SS; Conti MA; Kawamoto S; Claycomb WC; Adelstein RS
Mol Biol Cell; 2010 Nov; 21(22):3952-62. PubMed ID: 20861308
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.
van Houdt WJ; Hoogwater FJ; de Bruijn MT; Emmink BL; Nijkamp MW; Raats DA; van der Groep P; van Diest P; Borel Rinkes IH; Kranenburg O
Neoplasia; 2010 Jun; 12(6):443-52. PubMed ID: 20563247
[TBL] [Abstract][Full Text] [Related]
12. The F-BAR protein PACSIN2 regulates epidermal growth factor receptor internalization.
de Kreuk BJ; Anthony EC; Geerts D; Hordijk PL
J Biol Chem; 2012 Dec; 287(52):43438-53. PubMed ID: 23129763
[TBL] [Abstract][Full Text] [Related]
13. Nonmuscle myosin II isoform and domain specificity during early mouse development.
Wang A; Ma X; Conti MA; Liu C; Kawamoto S; Adelstein RS
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14645-50. PubMed ID: 20679233
[TBL] [Abstract][Full Text] [Related]
14. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
[TBL] [Abstract][Full Text] [Related]
15. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.
Yu XW; Lin S; Du HZ; Zhao RP; Feng SY; Yu BY; Zhang LY; Li RM; Qian CM; Luo XJ; Yuan ST; Sun L
Oncotarget; 2016 May; 7(22):32990-3003. PubMed ID: 27105508
[TBL] [Abstract][Full Text] [Related]
17. Nonmuscle myosin II folds into a 10S form via two portions of tail for dynamic subcellular localization.
Kiboku T; Katoh T; Nakamura A; Kitamura A; Kinjo M; Murakami Y; Takahashi M
Genes Cells; 2013 Feb; 18(2):90-109. PubMed ID: 23237600
[TBL] [Abstract][Full Text] [Related]
18. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
[TBL] [Abstract][Full Text] [Related]
19. Regulation of EGF-induced ERK/MAPK activation and EGFR internalization by G protein-coupled receptor kinase 2.
Gao J; Li J; Ma L
Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):525-31. PubMed ID: 16077899
[TBL] [Abstract][Full Text] [Related]
20. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
Maretzky T; Zhou W; Huang XY; Blobel CP
Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
